Cytotoxicity of intracanal dressings on apical papilla cells differ upon activation with E. faecalis LTA

Abstract Objective The aim of this study was to investigate the cytotoxic effects of modified triple antibiotic paste and an experimental composition using calcium hydroxide on lipoteichoic acid (LTA)-primed apical papilla cells (APC). Material and Methods Human APC were tested for in vitro cytotoxicity of modified Triple Antibiotic Paste (mTAP - Ciprofloxacin, Metronidazole and Cefaclor at 1:1:1) and of a paste of Ciprofloxacin, Metronidazole and Calcium hydroxide (CMC - 1:1:2) and modified CMC (mCMC - 2:2:1) by using MTT assay. The substances were reconstituted in DMEM at 1,000 µg/mL and » serially diluted before being kept in contact with cells for 1, 3, 5 and 7 days. Further, cells were primed with 1 µg/mL of Enterococcus faecalis LTA for 7 days prior to the viability test with 1,000 µg/mL of each substance. Statistical analysis was performed using one-way analysis of variance (ANOVA) and two-way ANOVA respectively followed by Tukey's post-test. Significance levels were set at p<0.05. Results In the first assay, the higher cytotoxic rates were reached by mTAP for all experimental periods. CMC was found toxic for APC at 5 and 7 days, whereas mCMC did not affect the cell viability. Only CMC and mCMC were able to induce some cellular proliferation. In the second assay, when considering the condition with medium only, LTA-primed cells significantly proliferated in comparison to LTA-untreated ones. At this context, mTAP and CMC showed similar cytotoxicity than the observed for LTA-untreated cells, while mCMC was shown cytotoxic at 7 days only for LTA-primed APC. Comparing the medications, mTAP was more cytotoxic than CMC and mCMC. Conclusion mTAP showed higher cytotoxicity than CMC and mCMC and the effect of topic antimicrobials might differ when tested against apical papilla cells under physiological or activated conditions.

Mesenchymal stem cells in the dental tissues: perspectives for tissue regeneration

In recent years, stem cell research has grown exponentially owing to the recognition that stem cell-based therapies have the potential to improve the life of patients with conditions that range from Alzheimer’s disease to cardiac ischemia and regenerative medicine, like bone or tooth loss. Based on their ability to rescue and/or repair injured tissue and partially restore organ function, multiple types of stem/progenitor cells have been speculated. Growing evidence demonstrates that stem cells are primarily found in niches and that certain tissues contain more stem cells than others. Among these tissues, the dental tissues are considered a rich source of mesenchymal stem cells that are suitable for tissue engineering applications. It is known that these stem cells have the potential to differentiate into several cell types, including odontoblasts, neural progenitors, osteoblasts, chondrocytes, and adipocytes. In dentistry, stem cell biology and tissue engineering are of great interest since may provide an innovative for generation of clinical material and/or tissue regeneration. Mesenchymal stem cells were demonstrated in dental tissues, including dental pulp, periodontal ligament, dental papilla, and dental follicle. These stem cells can be isolated and grown under defined tissue culture conditions, and are potential cells for use in tissue engineering, including, dental tissue, nerves and bone regeneration. More recently, another source of stem cell has been successfully generated from human somatic cells into a pluripotent stage, the induced pluripotent stem cells (iPS cells), allowing creation of patient- and disease-specific stem cells. Collectively, the multipotency, high proliferation rates, and accessibility make the dental stem cell an attractive source of mesenchymal stem cells for tissue regeneration. This review describes new findings in the field of dental stem cell research and on their potential use in the tissue regeneration.

Nos últimos anos, as pesquisas com células tronco têm aumentado exponencialmente devido ao reconhecimento de que seu potencial terapêutico pode melhorar a qualidade de vida de pacientes com diversas doenças, como a doença de Alzheimer, isquemias cardíacas e, até mesmo, nas pesquisas de medicina regenerativa que visa uma possível substituição de órgão perdidos, como por exemplo, os dentes. Baseado em habilidades de reparar tecidos injuriados e restaurar parcialmente as funções de um órgão, diversos tipos de células-tronco têm sido estudadas. Recentes evidências demonstram que as células-tronco são primariamente encontradas em nichos e que certos tecidos apresentam mais células-tronco que outros. Entre estes, os tecidos dentais são considerados como uma fonte rica de células-tronco mesenquimais adequado para aplicações em engenharia tecidual. Sabe-se que estas células têm o potencial de diferenciarem-se em diversos tipos celulares, incluindo osteoblastos, células progenitoras de neurônios, osteoblastos, condrócitos e adipósitos. Na odontologia, a biologia celular e a engenharia tecidual são de grande interesse, pois fornecem inovações na geração de novos materiais clínicos e ou na regeneração tecidual. Estas podem ser isoladas e crescidas em diversos meios de cultura apresentando grande potencial para ser usada na engenharia tecidual, incluindo regeneração de tecidos dentais, nervos e ossos. Recentemente, outra fonte de células tronco tem sido geradas a partir de células somáticas de humanos a um estágio de pluripotência, chamados de células-tronco pluripotente induzida (iPS) levando à criação de células-tronco específicas. Coletivamente, a multipotencialidade, altas taxas de proliferação e acessibilidade, faz das células-tronco dentárias uma fonte atrativa de células-tronco mesenquimais para regeneração tecidual. Esta revisão descreve novos achados no campo da pesquisa com células-tronco dentais e seu potencial uso na regeneração tecidual.